IRWD

Ironwood Pharmaceuticals
$3.91
+$0.20 (+5.39%)Jul 27, 2026
9.7GreatMoatMint rating

MoatMint rates Ironwood Pharmaceuticals (IRWD) 9.7 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 9.2 out of 10.

Key metrics

The numbers that frame IRWD today
Market cap
$643.64M
P/E (TTM)
6.3
EV / FCF
9.1
Gross margin
100%
EV / Sales
2.8
ROIC
35.2%
Div yield
0%
52wk Low
$0.72
52wk High
$5.78

IRWD stock rating

How IRWD scores on quality, value, growth, momentum and financial health
9.7out of 10
Great overallStrong business, attractive priceTop 3% of ~5,000 US stocks
QualityGreat9.2/10
GrowthGreat9.6/10
MomentumGreat9.7/10
ValueGreat9.5/10
Financial HealthPoor0.3/10

Growth

Revenue and earnings trend for IRWD
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about IRWD
Is Ironwood Pharmaceuticals a good buy?
Yes. Ironwood Pharmaceuticals has excellent quality and excellent momentum. Both signals support the setup. Growth looks excellent, which supports the long-term business case. We think Ironwood Pharmaceuticals is selling at a low price.
What is the market capitalization of IRWD?
Ironwood Pharmaceuticals's market capitalization is $643.64M.
What is the P/E ratio for IRWD stock?
Ironwood Pharmaceuticals's current P/E ratio is 6.3.
What is the 52-week high for IRWD stock?
The 52-week high for Ironwood Pharmaceuticals is $5.78. The current close of $3.91 is 32.4% below that high.
What is the 52-week low for IRWD stock?
The 52-week low for Ironwood Pharmaceuticals is $0.72. The current close of $3.91 is 446.9% above that low.
Does IRWD stock pay dividends?
Ironwood Pharmaceuticals does not currently show a dividend per share in the company data.